Volume | 711 |
|
|||||
Actualités | - | ||||||
Maximum Haut | 3,04 | Bas Haut |
|||||
Minimum Bas | 2,75 |
Nom Action | Symbole Action | Marché | Type |
---|---|---|---|
Anebulo Pharmaceuticals Inc | ANEB | NASDAQ | Action ordinaire |
Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
---|---|---|---|---|
2,75 | 2,75 | 3,04 | 2,78 | 2,85 |
Transactions Totales | Volume échangé | VWAP | Volume Financier | Volume en moyenne | Sur 52 semaines |
---|---|---|---|---|---|
53 | 711 | US$ 2,77 | US$ 1 967 | - | 1,62 - 4,05 |
Dernière Transaction | Type | Quantités échangées | Prix transaction | Devise |
---|---|---|---|---|
22:00:00 | 172 | US$ 2,78 | USD |
Bilan Comptable
Capitalisation Boursière | Actions en Circulation | Float | Chiffre d'affaires | Bénéfice/Perte | BPA | Ratio Cours sur Bénéfices |
---|---|---|---|---|---|---|
72,35M | 25,93M | - | 0 | -11,73M | -0,45 | - |
Short Interest | Dividendes Par Action | Rendement du Dividende | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
plus d’informations financières »
Actualités Action Anebulo Pharmaceuticals
Date | Heure | Source | Titre |
---|---|---|---|
13/2/2024 | 22:30 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
13/2/2024 | 22:15 | Edgar (US Regulatory) | Form 8-K - Current report |
13/2/2024 | 22:05 | Business Wire | Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year.. |
21/11/2023 | 22:01 | Edgar (US Regulatory) | Form 8-K - Current report |
14/11/2023 | 22:05 | Business Wire | Anebulo Pharmaceuticals Reports First Quarter Fiscal Year.. |
30/10/2023 | 14:31 | Edgar (US Regulatory) | Form ARS - Annual Report to Security Holders |
30/10/2023 | 14:22 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
19/10/2023 | 23:18 | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements |
06/10/2023 | 22:10 | Edgar (US Regulatory) | Form 8-K - Current report |
06/10/2023 | 22:06 | Business Wire | Anebulo Pharmaceuticals Announces New CEO |
02/10/2023 | 23:01 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of.. |
22/9/2023 | 22:05 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
Forum Action Anebulo Pharmaceuticals
Aucune Discussion TrouvéeAjouter une Discussion
Historiques Anebulo Pharmaceuticals Inc
Période | Ouver. | Haut | Bas | VWAP | Moyenne Vol. Quot. | Variation | % |
---|---|---|---|---|---|---|---|
1 semaine | 2,99 | 3,30 | 2,73 | 2,90 | 3 595 | -0,21 | -7,02% |
1 mois | 2,40 | 3,30 | 2,40 | 2,81 | 5 868 | 0,38 | 15,83% |
3 mois | 2,40 | 3,30 | 2,40 | 2,70 | 6 060 | 0,38 | 15,83% |
6 mois | 2,53 | 3,30 | 1,87 | 2,38 | 10 779 | 0,25 | 9,88% |
1 an | 2,96 | 4,05 | 1,62 | 2,49 | 9 475 | -0,18 | -6,08% |
3 ans | 7,38 | 9,33 | 1,62 | 4,63 | 10 478 | -4,60 | -62,33% |
5 ans | 7,38 | 9,33 | 1,62 | 4,63 | 10 478 | -4,60 | -62,33% |